Costs of an early reperfusion project for the treatment of ST-segment elevation acute coronary syndrome in the public sector of the Alto Valle, Province of Río Negro

Authors

  • Sonia Costantini Federación Argentina de Cardiología - Especialistas en Cardiología SRL, Argentina
  • Ricardo Bernztein Hospital Garrahan, Buenos Aires, Argentina
  • José Mármol Técnico de Estadística en Salud, Argentina
  • José Pereyra Colegio Argentino de Cardio angiólogos Intervencionistas (CACI) - Fundación Médica de Río Negro y Neuquén, Argentina
  • Martín Cari Colegio Argentino de Cardio angiólogos Intervencionistas (CACI) - Policlínico Modelo de Cipolletti, Argentina
  • Laura Moran Hospital Francisco López Lima, Río Negro, Argentina
  • Andrés Bogado Especialistas en Cardiología SRL - Hospital Villa Regina, Río Negro, Argentina
  • Alejandro Esteban Federación Argentina de Cardiología - Especialistas en Cardiología SRL, Argentina
  • Juan A Sánchez Federación Argentina de Cardiología - Especialistas en Cardiología SRL, Argentina
  • Ivana Muratore Federación Argentina de Cardiología - Especialistas en Cardiología SRL, Argentina

Keywords:

Reperfusion, Angioplasty, Thrombolysis, Cost-Effectiveness, ST-Segment Elevation Acute Coronary Syndrome (STEACS)

Abstract

Introduction: in the public sector of the Alto Valle of Rio Negro (RN) a healthcare issue has been identified concerning the management of ST-segment elevation acute coronary syndrome (STEACS). An opportunity to improve this situation would be the implementation of an early reperfusion project. Objective: to estimate the costs of an early reperfusion project with prehospital/hospital thrombolysis and primary PCI (pPCI) in patients with STEACS. Methodology: the study is framed as a health economic evaluation. The cost estimation was conducted using a macro-costing technique with a cost-of-illness approach. Results: the total estimated cost of the project was US$ 2,422,783.91. According to the expected cases and based on the projections made, in the first year of the project, we would expect to treat 66 STEMI patients, with a program cost of US$10,791.19/patient, a cost of stay of US$1,640.01/day, and an average stay of 6.58 days. By the end of the program, we would aim to treat 131 patients at a cost of US$ 2,066.93/patient and a cost per day of stay of US$ 645.92, with an average stay of 3 days. Conclusions: In the public healthcare sector of the Alto Valle of RN, reperfusion times for STEMI are prolonged, highlighting the need for the implementation of an early reperfusion project. For patients undergoing pPCI, initial costs are high, but they are offset by a shorter hospital stay. In the case of treatment with thrombolysis, costs are higher due to the need for coronary angiography with a probable PCI.

Downloads

Published

2025-03-28

How to Cite

1.
Costs of an early reperfusion project for the treatment of ST-segment elevation acute coronary syndrome in the public sector of the Alto Valle, Province of Río Negro. Rev. Fed. Arg. Cardiol. [Internet]. 2025 Mar. 28 [cited 2025 Apr. 19];54(1):50-8. Available from: https://revistafac.org.ar/ojs/index.php/revistafac/article/view/644